蓓蕾莉生技 ACL Biomedical

2026 FITme Anniversary – Taiwan Experts Experience Meeting Concludes Successfully

aclmedm02 — Thu, 30 Apr 2026 03:52:34 +0000

2026 FITme Anniversary – Taiwan Experts Experience Meeting Concludes Successfully

From Virtual to Real: Advancing from Design Planning to Clinical Execution

ACL Biomedical successfully held the FITme Anniversary – Taiwan Experts Experience Meeting on April 26, 2026. Plastic surgeons from across Taiwan gathered for active exchange, with discussions spanning clinical experience and surgical approaches.

The meeting featured Inhee Lee, FITme Director from Korea, who introduced the latest Face On 3D simulation and 3D scanning technologies, highlighting the integrated FITme workflow from planning to clinical application and the value of customized implants in practice.

Speakers also shared insights on Asian rhinoplasty trends, 3D printing technology, and clinical cases, with interactive discussions enhancing knowledge exchange.

ACL Biomedical will continue to integrate global technology with clinical expertise to advance medical innovation in Taiwan.

Special thanks to Dr. Hsu Ying-Che, Dr. Chang-Chien Shih-Huang, Dr. Hsieh Sung-Yu, Dr. Liu Chang-Chieh, and Dr. Lai Hsin-Ti for their valuable contributions.

※ Special thanks to ETtoday for the feature report: https://www.ettoday.net/news/20260428/3156845.htm

※ Special thanks to mnews for the feature report: https://www.mnews.tw/story/20260428mkt00003

Back

The post 2026 FITme Anniversary – Taiwan Experts Experience Meeting Concludes Successfully first appeared on 蓓蕾莉生技 ACL Biomedical.

2026 FITme Live Surgery Concludes Successfully

aclmedm02 — Thu, 23 Apr 2026 05:49:27 +0000

2026 FITme Live Surgery Concludes Successfully

From Crooked Nose Assessment to Customized Implant Applications: Showcasing Key Clinical Practices

The FITme Live Surgery, hosted by ACL Biomedical, was successfully held on April 18, 2026 at BOGEN Clinic, featuring Dr. Chang-Chien as the instructor.

The session focused on crooked nose assessment, surgical planning, and the application of customized implants in rhinoplasty. Through a live surgical demonstration with professional commentary and Q&A, the event highlighted key clinical decision-making from planning to execution.

Dr. Chang-Chien also shared experience in filler nose removal, followed by an in-depth discussion with attending physicians, encouraging professional exchange.

We sincerely thank all participating physicians and Dr. Chang-Chien for their valuable contributions. ACL Biomedical will continue to promote clinical innovation and medical advancement in Taiwan.

Back

The post 2026 FITme Live Surgery Concludes Successfully first appeared on 蓓蕾莉生技 ACL Biomedical.

ACL Biomedical 2026 Kick-Off Meeting

aclmedm02 — Fri, 27 Mar 2026 09:26:49 +0000

ACL Biomedical 2026 Kick-Off Meeting

Moving Forward Together Toward a New Chapter

ACL Biomedical successfully held its 2026 Kick-Off Meeting today, hosted by Managing Director LiLi, bringing together all team members to reflect on the past year and set the direction for the year ahead.

During the meeting, LiLi led the team in reviewing key developments and transitions throughout 2025. In a dynamic and evolving market environment, the team demonstrated resilience and adaptability, strengthening collaboration and building a more solid foundation for future growth.

Following this, department leaders presented their 2025 performance highlights and outlined strategic plans for 2026. The presentations covered key areas including sales strategies and market expansion, new product development initiatives, as well as upcoming marketing campaigns and brand-building efforts. These discussions helped align the entire organization toward clear goals and execution priorities for the coming year.

After the meeting, a team lunch was arranged, providing an opportunity for colleagues to connect, exchange ideas, and celebrate together, bringing the event to a warm and meaningful close.

Looking ahead, ACL Biomedical will continue to strengthen team synergy, move forward with confidence, and pursue the next phase of growth with a clear and focused vision.

Back

The post ACL Biomedical 2026 Kick-Off Meeting first appeared on 蓓蕾莉生技 ACL Biomedical.

MicroAire Asia-Pacific (APAC) Team Visits Taiwan for Clinical Observation at New Delight Medical Clinic

aclmedm02 — Wed, 18 Mar 2026 08:46:04 +0000

MicroAire Asia-Pacific (APAC) Team Visits Taiwan for Clinical Observation at New Delight Medical Clinic

Strengthening Clinical Exchange and Advancing Power-Assisted Liposuction Applications

On March 17, 2026, ACL Biomedical welcomed the MicroAire Asia-Pacific (APAC) Team to Taiwan for an official visit, including a clinical observation session at New Delight Medical Clinic. The delegation engaged in professional discussions with Mr. Tzi Tzer Ang, Regional Sales Director of MicroAire APAC, focusing on device operation and current developments in power-assisted liposuction technology.

During the visit, Dr. Yen-Chou Chen, Director of New Delight Medical Clinic, performed a live demonstration of a PAL-assisted liposuction procedure, highlighting its application in clinical practice. Dr. Wai-Man Wong from Hong Kong also participated in the exchange, sharing regional clinical perspectives and contributing to cross-market discussions.

ACL Biomedical continues to foster international collaboration by connecting global medical resources with local clinical expertise, supporting the ongoing advancement of medical technologies through professional exchange.

Back

The post MicroAire Asia-Pacific (APAC) Team Visits Taiwan for Clinical Observation at New Delight Medical Clinic first appeared on 蓓蕾莉生技 ACL Biomedical.

ACL Biomedical’s 2026 Year-End Celebration Successfully Concluded

aclmedm02 — Fri, 06 Feb 2026 02:36:51 +0000

ACL Biomedical’s 2026 Year-End Celebration Successfully Concluded

Thank you for a year of hard work and shared journey

ACL Biomedical Co., Ltd. held its year-end celebration on February 6. In a warm and relaxed setting, colleagues enjoyed food, singing, games, and a surprise raffle, creating joyful moments that reflected a year of shared efforts.

Managing Director Lili Hu expressed her gratitude to all team members, encouraging continued growth and mutual support. The company also expressed its appreciation for everyone’s professionalism and consistent contributions.

Looking ahead, ACL will continue moving forward together with the team—transforming daily dedication into meaningful progress while working collectively to enhance service quality and brand value.

Back

The post ACL Biomedical’s 2026 Year-End Celebration Successfully Concluded first appeared on 蓓蕾莉生技 ACL Biomedical.

ACL Biomedical Attends the MicroAire 2026 International Sales Meeting

aclmedm02 — Thu, 22 Jan 2026 06:58:31 +0000

ACL Biomedical Attends the MicroAire 2026 International Sales Meeting

Enhancing Global Medical Device Partnerships in Prague, Czech Republic

On January 22, 2026, the Managing Director of ACL Biomedical Co., Ltd. traveled to Prague, Czech Republic, to attend the International Sales Meeting hosted by MicroAire.

The event brought together 115 global partners from 42 countries, fostering an environment for experience sharing, product demonstrations, and strategic discussions. Through these exchanges, the meeting further strengthened cross‑border collaboration and deepened market insights.

．Conference Highlights

The meeting featured expert presentations on clinical applications and market insights, creating an energetic and engaging atmosphere. Remco Maljers, MicroAire’s Head of International Sales, expressed appreciation for the commitment of global partners and shared strong optimism for the year ahead. Participants agreed that the event offered solid insights and meaningful exchanges, marking a successful conclusion.

．Participation and Key Takeaways

Discussions focused on sales strategies, clinical needs, and local practice scenarios. The meeting also highlighted upcoming developments and practical applications of MicroAire’s surgical instruments, helping enhance service capabilities and professional support in various markets. This gathering is expected to strengthen future collaboration as MicroAire works closely with partners toward a more robust and forward‑looking global presence.

Back

The post ACL Biomedical Attends the MicroAire 2026 International Sales Meeting first appeared on 蓓蕾莉生技 ACL Biomedical.

ACL Biomedical Joins the UN SME Climate Hub and the Race to Zero Campaign, Committing to Net-Zero Carbon Emissions

aclmedm02 — Thu, 22 Jan 2026 05:46:52 +0000

ACL Biomedical Joins the UN SME Climate Hub and the Race to Zero Campaign, Committing to Net-Zero Carbon Emissions

Starting the Journey of Corporate Carbon Reduction Through Medical Innovation

In response to global climate change and in pursuit of corporate sustainability, ACL Biomedical Co., Ltd. has officially joined the United Nations SME Climate Hub and the Race to Zero campaign, aligning with SMEs worldwide in a shared commitment to a net-zero future.

🌍 What Is the SME Climate Hub and Race to Zero Net-Zero Badge?

The SME Climate Hub is an international platform jointly launched by the We Mean Business Coalition, the Exponential Roadmap Initiative, and the UN Climate Change High-Level Champions, serving as the official pathway for small and medium-sized enterprises (SMEs) to participate in the Race to Zero campaign.

By joining the SME Climate Hub, SMEs are able to take a science-based and strategic approach to gradually advancing emissions reduction actions. Participating companies are also formally included in the United Nations Race to Zero global roster, joining businesses, cities, and organizations worldwide in working toward a net-zero future.

Becoming part of this initiative signifies that ACL Biomedical has officially aligned with United Nations climate action, closely linking its corporate operations with global sustainability goals and contributing to long-term, responsible growth within the healthcare industry.

🔍 Why is ACL Biomedical committing to net-zero at this time?

As a company focused on medical technology, ACL Biomedical recognizes that “protecting health” goes beyond its products and services—it also encompasses the environment and society we live in.

After reviewing its operational structure, ACL Biomedical found that the company’s carbon emissions sources are relatively simple and clear, mainly concentrated in two key areas:

🔹 Vehicle fuel used for staff travel and deliveries

This includes daily operational transportation, such as business visits and product deliveries.

🔹 Purchased electricity for offices in Taipei and Kaohsiung

This covers electricity needs for daily office work, administration, and operational support.

This clear emission structure allows ACL Biomedical to advance emissions reduction initiatives in a practical, feasible, and trackable manner, rather than relying on slogan-driven sustainability commitments.

🔧 ACL Biomedical’s Net-Zero starting point: Advancing future action Strategies and Sustainability plans

To fulfill its commitment to the SME Climate Hub and the Race to Zero campaign, ACL Biomedical will progressively advance the following key initiatives:

📣 The ESG Vision of ACL Biomedical

Obtaining recognition for its net-zero commitment through the SME Climate Hub and the Race to Zero campaign not only reflects ACL Biomedical’s international commitment to climate action, but also signifies our willingness to stand alongside businesses around the world in addressing climate challenges, strengthening corporate resilience, and creating positive impacts for society and the environment.

We believe that regardless of company size, every organization can contribute to global sustainability by taking the first step. When collective actions come together, they become a powerful force in advancing meaningful change. While safeguarding human health, we are also committed to doing our part to protect the future of our planet.

Looking ahead, ACL Biomedical will adopt an even more proactive approach to implementing its Environmental, Social, and Governance (ESG) strategy, working together with all our partners to co-create a sustainable future for the healthcare industry.

Back

The post ACL Biomedical Joins the UN SME Climate Hub and the Race to Zero Campaign, Committing to Net-Zero Carbon Emissions first appeared on 蓓蕾莉生技 ACL Biomedical.

ACL Biomedical featured at the Taiwan Society of Plastic Surgery Annual Meeting

aclmedm02 — Tue, 16 Dec 2025 07:04:13 +0000

ACL Biomedical featured at the Taiwan Society of Plastic Surgery Annual Meeting

Showcasing innovative medical technologies, capturing strong interest from professional surgeons

Last weekend, ACL Biomedical made a prominent appearance at the Taiwan Society of Plastic Surgery Annual Meeting, presenting a range of innovative international medical devices and post-operative care solutions. These included GalaFLEX, FITme, PAL(Power Assister Lipoplasty), and 柔膜萃(post-surgery care products).

The event attracted numerous leading surgeons who engaged in in-depth discussions on topics such as breast reconstruction, revision augmentation, and body contouring techniques. ACL remains committed to providing physicians with comprehensive professional resources and clinical insights, enabling the precise application of medical devices and advancing the quality and safety standards of aesthetic medicine in Taiwan.

We were also honored to reconnect with Dr. Perin, the international speaker who previously spoke at our GalaFLEX Breast Reconstruction Experts Experience Meeting, sharing invaluable professional insights. This gathering was not only a technical exchange but also a meaningful bridge connecting global medical trends with Taiwan’s expertise.

Back

The post ACL Biomedical featured at the Taiwan Society of Plastic Surgery Annual Meeting first appeared on 蓓蕾莉生技 ACL Biomedical.

2025 GalaFLEX Breast Reconstruction Experts Experience Meeting

aclmedm02 — Tue, 02 Dec 2025 02:00:05 +0000

2025 GalaFLEX Breast Reconstruction Experts Experience Meeting

International Experts Gather to Share Key Clinical Insights

On November 29, 2025, the GalaFLEX Breast Reconstruction Experts Experience Meeting brought together leading domestic and international experts in reconstructive surgery to exchange insights and share diverse clinical cases, offering an in-depth exploration of GalaFLEX’s applications in reconstructive procedures.

The meeting was chaired by Dr. Tai and Dr. Lee, with clinical experience shared by Dr. Lu, Dr. Feng, and Dr. An-Chieh Feng joining remotely. In addition, the BD headquarters invited Brazilian speakers Dr. Perin and Dr. Graziosi to provide frontline international perspectives, delivering content that was both in-depth and highly practical.

ACL will continue to advance professional physician education, striving to be the most steadfast supporter in the field of reconstructive medical devices, working alongside physicians to enhance the quality of clinical care.

※ Special thanks to ETtoday for the feature report: https://health.ettoday.net/news/3076528

※ Special thanks to Watch Media for the feature report: https://www.watchmedia01.com/archives/466170

Back

The post 2025 GalaFLEX Breast Reconstruction Experts Experience Meeting first appeared on 蓓蕾莉生技 ACL Biomedical.

2025 Annual Meeting of the Taiwan Oncoplastic Breast Surgery Society

aclmedm02 — Tue, 18 Nov 2025 01:58:07 +0000

2025 Annual Meeting of the Taiwan Oncoplastic Breast Surgery Society

Sharing clinical applications and technical highlights of GalaFLEX at the event

On November 15–16, 2025, ACL Biomedical participated in the Annual Meeting of the Taiwan Oncoplastic Breast Surgery Society, held over two full days at TICC. Throughout the event, the GalaFLEX scaffold was showcased, highlighting its clinical applications and key technical features to attending surgeons.

This year’s meeting gathered local and international experts to discuss breast tumor surgery, reconstruction techniques, genetic risk assessment, and related topics. A patient forum also provided a platform for addressing key issues in clinical practice and care.

ACL Biomedical team also had the pleasure of meeting many partner physicians at the event and sincerely appreciates their support and guidance. Moving forward, we will continue to introduce and promote high-quality medical products and clinical resources, aiming to contribute to a more comprehensive enhancement of the healthcare environment.

Back

The post 2025 Annual Meeting of the Taiwan Oncoplastic Breast Surgery Society first appeared on 蓓蕾莉生技 ACL Biomedical.